Identifying the Right Investigators and Patients for your Study – Mini Podcast Biosimilar Development Capabilities – Watch Now Vaccine Development Capabilities - Brochure Check out our latest Validated PK & ADA Methods List Read about Veeda's partnership with Ahammune Biosciences for first in human studies Check out our Assay List (Method Library)

Centre of Excellence for Analytics & Characterization

Analytics and characterization department at Biopharma Division of Veeda is a preferred solution partner for physicochemical, structural characterization, and analytical CMC support for a broad range of biotherapeutics including peptides, oligos, recombinant-conjugated -fusion proteins, monoclonal antibodies (mAbs), bispecific antibody fragments, antibody-drug conjugates, and biopolymers.

Expert Characterization for Biopharmaceuticals: From Glycosylated Proteins to Vaccines, We Deliver Precision

line

Primary Structure

Discover top-tier protein characterization with Veeda Group. Our expert scientists offer detailed analyses, from liquid chromatography to peptide sequencing, providing essential insights into amino acid composition, purity, and variants. With our advanced technologies, we deliver precision and excellence to propel your biopharmaceutical development forward.

Higher-Order Structure (HOS)

Explore our advanced methodologies in spectroscopy, calorimetry, and light scattering to uncover insights into tertiary and quaternary protein structures. Our expertise in protein conformers and secondary structure analysis offers a deeper understanding of your biopharmaceutical’s stability and functionality.

Innovative ZipChip Collaboration Enhancing Precision In Charge Variant Characterization

line

CMC analytical testing is a critical component of all drug development programs. These sophisticated assays monitor drug manufacturing processes to ensure the safety, efficacy, and quality of pharmaceutical products. Recognizing the inherent complexity of CMC bioanalytical strategies, our services are meticulously tailored to meet the specific needs of each therapeutic program, providing you with the confidence and assurance needed for successful regulatory approval.

N-Glycan Analysis in 3-4 Days

  • Fully automated for rapid results
  • Cutting down processing time from weeks to days

Cell Line/Clone Selection

line
  • Protein sequence
  • Sequence variants characterization
  • PTM analysis
  • Glycosylation analysis
  • De novo sequencing

Upstream

line
  • Harvest titers
  • Identity
  • Purity
  • Glycosylation analysis
  • PTM analysis

Downstream

line
  • Size/charge variants
  • Refolding efficiency
  • Identity
  • Purity
  • Heterogeneity
  • Impurity
  • N-/O-glycans
  • Residuals (HCD, HCP, rProA)
  • Potency

Formulation

line
  • PTM quantification
  • Monitoring degradation
  • Excipient testing
  • MAM-based monitoring of selected PTMs
  • Studies on formulants role in protein stability

Drug Substance & Drug Product (DS & DP)

line
  • DS & DP Testing
  • Identity
  • Purity
  • Heterogeneity
  • Intact mass
  • Peptide map
  • Glycan analysis
  • Residuals
  • Potency

State-of-the-Art Veeda Biopharma Analytical Technologies

line

PA800 PLUS

Chirascan V100

INVENIO

Prominence LC

BioPharma Finder

Circular Dichroism Spectroscopy (CD)

Water Connect

AF2000 Modular SEC & FFF MALS

Litesizer

nanoDSC

QExactive Orbitrap

Xevo G3 QT

ZipChip CE-MS Device